Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma

Author(s):
Baranski, Z.; Booij, T.H.; Cleton-Jansen, A.M.; Price, L.S.; Water, B. van de; Bovee, J.V.M.G. (0000-0003-1155-0481); Hogendoorn, P.C.W. (0000-0002-1513-8104); Danen, E.H.J.
Published
2015
Publication type
Article / Letter to editor
osteosarcomaAvenChk1 inhibitorsdoxorubicin3D cell culture
Date issued
2015-07-31
Language
English
Is part of
Journal of Pathology (2015), Vol. 236, no. 3, p. 348-359
hdl
1887/107244
doi
10.1002/path.4528